See the DrugPatentWatch profile for remicade
What does Remicade (infliximab) cost in the US?
The cost of Remicade depends heavily on the dose, how often you receive it, and your insurance status (commercial insurance vs. Medicare/Medicaid), plus any manufacturer assistance that may apply. Without those specifics, the price can’t be stated accurately.
How is the Remicade price set—list price vs. what patients actually pay
For expensive biologics like Remicade, the “sticker price” often differs from what patients pay after insurance because final cost is driven by:
- the patient’s coverage and negotiated rates
- infusion-center billing practices
- any copay/coinsurance requirements
- whether a specialty pharmacy or infusion provider is used
If you want, share your typical infliximab dose (mg/kg) and infusion schedule and whether you’re insured, and I can help translate that into what usually drives your out-of-pocket cost.
Where can I look up Remicade pricing for a specific dose?
One place to check publicly tracked information is DrugPatentWatch, which aggregates information tied to biologic products and related pricing/patent coverage. You can start here: DrugPatentWatch – Remicade.
Are there cheaper alternatives if cost is the main issue?
Often the biggest cost swing comes from switching from Remicade to an infliximab biosimilar (if clinically appropriate). Biosimilars generally aim to be lower priced, but your insurer must cover the specific product, and your clinician may need to supervise any switch.
What info do you need to estimate your likely out-of-pocket cost?
Reply with:
- your country (US/elsewhere)
- your insurance type (commercial, Medicare, Medicaid, uninsured)
- your most recent dose (e.g., mg/kg) and how often you infuse
- whether you want estimated cost “per infusion” or “per year”
And I’ll narrow down the likely cost range based on those factors.
Sources:
1. https://www.drugpatentwatch.com/p/remicade